<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Fibrin formation is required for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>, <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and invasion </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> discovered at the same time as or shortly after venous <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> (VTE) tends to be advanced, and the prognosis poor </plain></SENT>
<SENT sid="2" pm="."><plain>Previous studies have demonstrated that plasma D-dimer - a degradation product of cross-linked fibrin - correlates with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> stage and prognosis in patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>However, it remains unclear whether D-dimer is of prognostic significance in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients with absence of VTE </plain></SENT>
<SENT sid="4" pm="."><plain>OBJECTIVE: To examine whether the preoperative plasma D-dimer level predicts 1-year survival in pre- and postoperative VTE-negative <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients admitted for surgery </plain></SENT>
<SENT sid="5" pm="."><plain>METHODS: We measured preoperative D-dimer levels in 157 patients, and computed Kaplan-Meier survival curves according to the levels of D-dimer </plain></SENT>
<SENT sid="6" pm="."><plain>Cox proportional-hazard regression analysis was used to compute hazard ratio as a measure of 1-year mortality rate ratio, controlling for potential confounding factors </plain></SENT>
<SENT sid="7" pm="."><plain>The Aalborg Hospital's standard cut-off level of 0.3 mg L(-1) was used to distinguish negative and positive D-dimer results </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: The overall 1-year survival rate was 87.3% (95% confidence interval (CI), 81.0-91.6%), with 78.1% survival (95% CI, 65.9-86.4%) in the positive D-dimer group compared with 93.6% survival (95% CI, 86.2-97.1%) in the negative D-dimer group </plain></SENT>
<SENT sid="9" pm="."><plain>The adjusted hazard ratio of <z:hpo ids='HP_0011420'>death</z:hpo> in the positive D-dimer group compared with the negative D-dimer group was 3.6 (95% CI, 1.3-9.9) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: A positive preoperative D-dimer is associated with a poor prognosis in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients with absence of VTE </plain></SENT>
</text></document>